Skip to main content
OpenTrials
Completed

NCT Number: NCT06229561

Soft Tissue Graft Versus Acellular Dermal Matrix in Preservation of Buccal Plate of Bone

Comparative study between 2 groups to assess the feasibility of using Acellular dermal matrix vs Soft tissue Graft after immediate implant placement

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

20 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Azhar University

Nāşir, Egypt

About this study

It was conclude that SCTG is the gold standard for soft tissue augmentation up till now, However ADM can be alternative to autogenous soft tissue graft.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Medically free

Exclusion criteria

Heavy smoking

Treatment and study plan

Acellular Dermal Matrix

Combination Product

Feasibility of soft tissue graft after immediate implant placement

Primary outcomes

  1. Buccal bone thickness

    Time frame: 6 months follow up

    Assess the buccal bone thickness before and after the graft application

Sponsors and collaborators

Lead sponsor

Faculty of Dental Medicine for Girls

Other Gov

Registry information

Official study title

Soft Tissue Graft Versus Acellular Dermal Matrix in Preservation of Buccal Plate of Bone After Immediate Implant Placement

Important dates

Study start
2020
Primary completion
2022
Study completion
2023
First posted
Jan 29, 2024
Registry last updated
Jan 29, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.